ACXP
HEALTHCAREAcurx Pharmaceuticals Inc
$2.09+0.09 (+4.50%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ACXP Today?
No stock-specific AI insight has been generated for ACXP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.33$21.00
$2.09
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-5.32
Dividend Yield—
Dividend / Share—
ROE-2.7%
Profit Margin—
Debt / Equity—
Trading
Volume70K
Avg Volume (10D)—
Shares Outstanding2.9M
ACXP News
20 articles- Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026Yahoo Finance·May 4, 2026
- Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseYahoo Finance·Apr 29, 2026
- Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor SummitYahoo Finance·Apr 27, 2026
- Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business UpdateYahoo Finance·Apr 20, 2026
- New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)Yahoo Finance·Apr 18, 2026
- Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesYahoo Finance·Apr 16, 2026
- Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesYahoo Finance·Apr 16, 2026
- New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)Yahoo Finance·Apr 11, 2026
- New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor EventsYahoo Finance·Apr 7, 2026
- New to The Street Announces Episode 741 Airing Tonight on Bloomberg Television at 6:30 PM EST Featuring Canton Networks, Acme Markets, Virtuix Holdings (VTIX), HPB, Jonas & Redman, Acurx Pharmaceuticals (ACXP), and FreeCast (CAST)Yahoo Finance·Apr 4, 2026
- Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Apr 2, 2026
- Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC InhibitorsYahoo Finance·Mar 30, 2026
- New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)Yahoo Finance·Mar 28, 2026
- Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ...Yahoo Finance·Mar 24, 2026
- Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?Yahoo Finance·Mar 19, 2026
- Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?Yahoo Finance·Mar 17, 2026
- Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business UpdateYahoo Finance·Mar 13, 2026
- BC-Most Active StocksYahoo Finance·Mar 11, 2026
- Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile InfectionYahoo Finance·Mar 9, 2026
- Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC InhibitorsYahoo Finance·Feb 24, 2026
All 20 articles loaded
Price Data
Open$0.00
Previous Close$2.00
Day High$0.00
Day Low$0.00
52 Week High$21.00
52 Week Low$1.33
52-Week Range
$1.33$21.00
$2.09
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-5.32
Dividend Yield—
Dividend / Share—
ROE-2.7%
Profit Margin—
Debt / Equity—
Trading
Volume70K
Avg Volume (10D)—
Shares Outstanding2.9M
About Acurx Pharmaceuticals Inc
Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—